rs138585448

Variant summary

Our verdict is Benign. The variant received -10 ACMG points: 0P and 10B. BP4_ModerateBP6_Very_Strong

The NM_152743.4(BRAT1):​c.361A>C​(p.Ser121Arg) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000161 in 1,568,368 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★). Synonymous variant affecting the same amino acid position (i.e. S121S) has been classified as Likely benign.

Frequency

Genomes: 𝑓 0.00084 ( 0 hom., cov: 30)
Exomes 𝑓: 0.000088 ( 0 hom. )

Consequence

BRAT1
NM_152743.4 missense

Scores

2
9
8

Clinical Significance

Likely benign criteria provided, multiple submitters, no conflicts B:3

Conservation

PhyloP100: 2.66

Publications

1 publications found
Variant links:
Genes affected
BRAT1 (HGNC:21701): (BRCA1 associated ATM activator 1) The protein encoded by this ubiquitously expressed gene interacts with the tumor suppressing BRCA1 (breast cancer 1) protein and and the ATM (ataxia telangiectasia mutated) protein. ATM is thought to be a master controller of cell cycle checkpoint signalling pathways that are required for cellular responses to DNA damage such as double-strand breaks that are induced by ionizing radiation and complexes with BRCA1 in the multi-protein complex BASC (BRAC1-associated genome surveillance complex). The protein encoded by this gene is thought to play a role in the DNA damage pathway regulated by BRCA1 and ATM. [provided by RefSeq, Mar 2012]
BRAT1 Gene-Disease associations (from GenCC):
  • neonatal-onset encephalopathy with rigidity and seizures
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Ambry Genetics, Orphanet, ClinGen, G2P, Labcorp Genetics (formerly Invitae)
  • neurodevelopmental disorder with cerebellar atrophy and with or without seizures
    Inheritance: AR Classification: DEFINITIVE Submitted by: ClinGen, Ambry Genetics

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -10 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.078555614).
BP6
Variant 7-2544978-T-G is Benign according to our data. Variant chr7-2544978-T-G is described in ClinVar as Likely_benign. ClinVar VariationId is 472967.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
BRAT1NM_152743.4 linkc.361A>C p.Ser121Arg missense_variant Exon 4 of 14 ENST00000340611.9 NP_689956.2

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
BRAT1ENST00000340611.9 linkc.361A>C p.Ser121Arg missense_variant Exon 4 of 14 1 NM_152743.4 ENSP00000339637.4
BRAT1ENST00000467558.5 linkn.377A>C non_coding_transcript_exon_variant Exon 3 of 10 5
BRAT1ENST00000469750.5 linkn.585A>C non_coding_transcript_exon_variant Exon 4 of 11 2
BRAT1ENST00000421712.1 linkn.283-1016A>C intron_variant Intron 2 of 4 3 ENSP00000409209.2

Frequencies

GnomAD3 genomes
AF:
0.000841
AC:
128
AN:
152174
Hom.:
0
Cov.:
30
show subpopulations
Gnomad AFR
AF:
0.00290
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000523
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00
Gnomad OTH
AF:
0.00
GnomAD2 exomes
AF:
0.000205
AC:
37
AN:
180178
AF XY:
0.000186
show subpopulations
Gnomad AFR exome
AF:
0.00283
Gnomad AMR exome
AF:
0.000190
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000132
Gnomad OTH exome
AF:
0.000212
GnomAD4 exome
AF:
0.0000876
AC:
124
AN:
1416076
Hom.:
0
Cov.:
31
AF XY:
0.0000800
AC XY:
56
AN XY:
700000
show subpopulations
African (AFR)
AF:
0.00294
AC:
96
AN:
32684
American (AMR)
AF:
0.000188
AC:
7
AN:
37164
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
24998
East Asian (EAS)
AF:
0.00
AC:
0
AN:
37818
South Asian (SAS)
AF:
0.00
AC:
0
AN:
80548
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
49416
Middle Eastern (MID)
AF:
0.000707
AC:
4
AN:
5660
European-Non Finnish (NFE)
AF:
0.00000275
AC:
3
AN:
1089050
Other (OTH)
AF:
0.000238
AC:
14
AN:
58738
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
7
15
22
30
37
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
4
8
12
16
20
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.000840
AC:
128
AN:
152292
Hom.:
0
Cov.:
30
AF XY:
0.000859
AC XY:
64
AN XY:
74482
show subpopulations
African (AFR)
AF:
0.00289
AC:
120
AN:
41572
American (AMR)
AF:
0.000523
AC:
8
AN:
15308
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3464
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5178
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4828
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10610
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.00
AC:
0
AN:
68010
Other (OTH)
AF:
0.00
AC:
0
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.505
Heterozygous variant carriers
0
6
11
17
22
28
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
4
8
12
16
20
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000295
Hom.:
0
Bravo
AF:
0.000926
ESP6500AA
AF:
0.00253
AC:
11
ESP6500EA
AF:
0.000117
AC:
1
ExAC
AF:
0.000185
AC:
22

ClinVar

Significance: Likely benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

BRAT1-related disorder Benign:1
Jul 13, 2022
PreventionGenetics, part of Exact Sciences
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -

Neonatal-onset encephalopathy with rigidity and seizures Benign:1
Dec 24, 2024
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not provided Benign:1
Dec 29, 2020
GeneDx
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
0.84
BayesDel_addAF
Benign
-0.063
T
BayesDel_noAF
Pathogenic
0.14
CADD
Benign
23
DANN
Uncertain
1.0
DEOGEN2
Benign
0.019
T
Eigen
Uncertain
0.47
Eigen_PC
Uncertain
0.42
FATHMM_MKL
Uncertain
0.90
D
LIST_S2
Benign
0.79
T
M_CAP
Uncertain
0.13
D
MetaRNN
Benign
0.079
T
MetaSVM
Uncertain
0.32
D
MutationAssessor
Uncertain
2.3
M
PhyloP100
2.7
PrimateAI
Uncertain
0.62
T
PROVEAN
Benign
-1.9
N
REVEL
Uncertain
0.59
Sift
Benign
0.13
T
Sift4G
Benign
0.40
T
Polyphen
1.0
D
Vest4
0.87
MutPred
0.33
Gain of MoRF binding (P = 0.0273);
MVP
0.89
MPC
0.094
ClinPred
0.034
T
GERP RS
5.6
Varity_R
0.29
gMVP
0.70
Mutation Taster
=80/20
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs138585448; hg19: chr7-2584612; API